Member Info for ragingcow38

perhaps 'explode' isn't an apt word to use..

Gives his view this morning on stockopedia

Interesting

Looking fine

How can it be true to say 'We are pleased to report a successful half-year performance for the Group..'' by Dr. Clifford M. Gross, Chairman when there been share dilution and the figures below are nearly all down?
· Net Assets increased 16% to US$26.18m (30 Nov 2019: US$22.53m)
· NAV per share US$0.30 (30 Nov 2019: US$0.35)
· Total Revenue of US$2,859,647 (H1 2019: US$5,401,568)
o Net increase of US$2,422,949 in fair value of portfolio companies
· Revenue from services US$557,684 (H1 2019: $614,394)
· Reduction of operating expenses by 4% to US$711,300 (H1 2019: US$740,947).
o Service revenue cover appx. 58% of current cost base (H1 2019: 63%)
· Profit before tax of US$1,897,629 (H1 2019: US$4,421,279)
· Placements of 14,800,000 new ordinary shares of 0.4 pence each in the Company ("new ordinary shares") to raise gross proceeds of US$962,000 in February 2020 and 9,250,000 new ordinary shares to raise gross proceeds of US$1,115,000 in May 2020.

Another nice RNS today.
Klaas van der Leest, Intercede's CEO, said:
"We are delighted that MyID software will form the central element of the Department of State's next-generation IDMS. This contract win underlines the quality of our MyID software and its future in managing best in class digital identity solutions for security conscious organisations like the DoS. It also highlights the strength of our offering when working proactively with partners, following on from the recent launch of our Connect Partner Programme. Together with Guidehouse as the prime contractor, plus Appian Logic, Aware and CertiPath, we have an innovative solution that will meet the needs of the DoS now and over the next ten years."
Intercede expects to receive a further order for software licenses and associated development, professional services and support & maintenance within the next few months; a portion of which will be recognised in the current financial year ending 31 March 2021.
The contract was included within the directors' expectations for the current financial year ending 31 March 2021.

you at one post should know or ... oh sorry

Oh please the sentiment is astonishingly crude.
No doubt your one of the paid disciples in a far flung region of nether land,

Long way to go to reach the fake news of Will I Am days of 2014... here's hoping for 38p plus1

the LSE shows that the following happened
a BUY at 16.35.08 Off Book £2,486,668.18
and a SELL at 16.37.35 UT £2, 378,700.00
rounding down to £2m on this site... well....

forgive me; they are showing as sells on this board?

Charles Spicer, Chairman of Creo, today purchased 24,509 ordinary shares of £0.001 each in the capital of the Company ('Ordinary Shares') via his Self-Invested Personal Pension ('SIPP') at a price of 204 pence per Ordinary Share.

This is good news: Acquisition of Albyn Medical S.L.
Supplier of specialist healthcare products adds European commercial platform to Creo

re: Free float...is 70% small in your world?

bored?

''Cash at 30 June 2020 remained broadly flat at £4.4m, showing only a very marginal decrease since 31 April 2020.'' oops doesn't give me great confidence in this company. Basic proof reading error. However, i can see decent some upside potential.

it'll be more helpful if you'd give a time frame for your rather loose statement.

Encouraging!

Agreed. Hope the JV isn't as poor.

that too!